(1) Poll Results of the Extraordinary General Meeting Held on 24 November 2022; and (2) Grant of the Whitewash Waiver
Despatch of Circular in relation to (I) Proposed Rights Issue on the Basis of One (1) Rights Share for Every One (1) Existing Share held on the Record Date; (II) Connected Transactions in relation to the Underwriting Agreement and Set Off of Shareholder’s Loans; (III) Application for Whitewash Waiver; and (IV) Possible Adjustments to the Share Options under the Share Option Scheme
Delay in Despatch of Circular in relation to (I) Proposed Rights Issue on the Basis of One (1) Rights Share for Every One (1) Existing Share held on the Record Date; (II) Connected Transactions in relation to the Underwriting Agreement and Set Off of Shareholder’s Loans; (III) Application for Whitewash Waiver; and (IV) Possible Adjustments to the Share Options under the Share Option Scheme
(I) Proposed Rights Issue on the Basis of One (1) Rights Share for Every One (1) Existing Share held on the Record Date; (II) Connected Transactions in relation to the Underwriting Agreement and Set Off of Shareholder’s Loans; (III) Application for Whitewash Waiver; and (IV) Possible Adjustments to the Share Options under the Share Option Scheme
Change of Address of Hong Kong Branch Share Registrar and Transfer Office
Deep Longevity published and granted the first microbiomic aging clock patent
Supplemental Announcement to the Circular of the Company dated 27 April 2022
Possible Major Transaction – Disposal Mandate in relation to the Possible Future Disposal of Listed Securities